P. Bakakos

发表

Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study)

S. Loukides, P. Bakakos, D. Papakosta, 2021, Pneumon.

Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects

K. Kostikas, S. Loukides, P. Bakakos, 2014 .

Modification of T-cell receptor Vbeta repertoire in response to allergen stimulation in peanut allergy.

J. Warner, J. Smith, E. Hodges, 2001, The Journal of allergy and clinical immunology.

The present and future of inhalation therapy for the management of obstructive airway diseases: Emphasis on pressurized metered-dose inhalers

K. Kostikas, S. Loukides, P. Steiropoulos, 2021, Pneumon.

A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014.

N. Rovina, A. Koutsoukou, D. Iliopoulos, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The role of induced sputum in asthma assessment

T. Tsaganos, S. Loukides, P. Bakakos, 2012 .

Induced sputum in asthma: from bench to bedside.

M. Alchanatis, F. Schleich, P. Bakakos, 2011, Current medicinal chemistry.

Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.

K. Kostikas, N. Koulouris, S. Loukides, 2013, Respiratory medicine.

Dual Bronchodilator in the Era of Triple Therapy

N. Tzanakis, S. Loukides, N. Rovina, 2020, International journal of chronic obstructive pulmonary disease.

Glycated Hemoglobin (HbA1c) as a Predictor of Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease

S. Loukides, S. Papiris, A. Papaioannou, 2021, COPD.

Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma.

N. Koulouris, S. Loukides, N. Rovina, 2015, Respiratory Medicine.

Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation

K. Kostikas, N. Koulouris, A. Spathis, 2018, Lung.

Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients

A. Koutsoukou, P. Bakakos, G. Kaltsakas, 2017, Respiratory Physiology & Neurobiology.

Serum periostin in patients hospitalized for COPD exacerbations

K. Kostikas, N. Koulouris, S. Loukides, 2015, Cytokine.

Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD

K. Kostikas, N. Koulouris, S. Loukides, 2016, Journal of cardiopulmonary rehabilitation and prevention.

Increased levels of osteopontin in sputum supernatant in patients with COPD.

K. Kostikas, N. Koulouris, S. Loukides, 2012, Chest.

Mucolytics in COPD : Like red wine ?

K. Kostikas, S. Loukides, P. Bakakos, 2013 .

Biomarkers in COPD: Is Mortality the Holy Grail?

K. Kostikas, S. Loukides, P. Bakakos, 2013, COPD.

Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD.

K. Kostikas, S. Loukides, S. Papiris, 2012, Cytokine.

Tuberculous Effusion: ADA Activity Correlates with CD4+ Cell Numbers in the Fluid and the Pleura

M. Gaga, G. Papamichalis, D. Orphanidou, 2005, Respiration.

Investigation of the health effects on workers exposed to respirable crystalline silica during outdoor and underground construction projects

D. Spandidos, A. Lazaris, E. Patsouris, 2020, Experimental and therapeutic medicine.

Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking

K. Kostikas, N. Koulouris, S. Loukides, 2015, European journal of clinical investigation.

Activin A and follistatin in patients with asthma. Does severity make the difference?

K. Kostikas, N. Koulouris, S. Loukides, 2017, Respirology.

Predictors of future exacerbation risk in patients with asthma

K. Kostikas, N. Koulouris, S. Loukides, 2016, Postgraduate medicine.

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma

K. Kostikas, N. Koulouris, G. Papatheodorou, 2015, Allergy.

Increased levels of osteopontin in sputum supernatant of smoking asthmatics.

K. Kostikas, N. Koulouris, S. Loukides, 2013, Cytokine.

Levels of prostaglandin E2 and Cysteinyl‐leukotrienes in sputum supernatant of patients with asthma: the effect of smoking

N. Koulouris, K. Kostikas, S. Papiris, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma

K. Kostikas, S. Papiris, S. Loukides, 2012, Allergy.

Increased levels of osteopontin in sputum supernatant in severe refractory asthma

S. Loukides, E. Tseliou, S. Papiris, 2010, Thorax.

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.

C. Roussos, S. Loukides, E. Tseliou, 2010, Chest.

Experimental and investigational phosphodiesterase inhibitors in development for asthma

S. Loukides, P. Bakakos, G. Hillas, 2019, Expert opinion on investigational drugs.

The asthma – COPD overlap syndrome : ACOS , CAOS or CHAOS ?

S. Loukides, K. Kostikas, P. Bakakos, 2014 .

Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis.

P. Bakakos, K. Dimakou, G. Hillas, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

EBC metabolomics for asthma severity

D. Benaki, S. Loukides, P. Bakakos, 2020, Journal of breath research.

THE HELLENIC THORACIC SOCIETY ( HTS ) THE GREEK BRONCHOLOGIC SOCIETY ( GBS )

Demosthenes Bouros, G. Stathopoulos, P. Bakakos, 2009 .

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes

N. Koulouris, K. Kostikas, S. Loukides, 2017, Allergy.

Simultaneous analysis of T cell clonality and cytokine production in rheumatoid arthritis using three‐colour flow cytometry

A. Frew, M. Cawley, J. Smith, 2002, Clinical and experimental immunology.

TCR usage and cytokine expression in peripheral blood and BAL T cells

A. Frew, J. Smith, C. Pickard, 2002, Clinical and experimental immunology.

Noninvasive evaluation of airway inflammation in patients with severe asthma.

K. Kostikas, S. Loukides, E. Tseliou, 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice.

S. Loukides, E. Tseliou, P. Bakakos, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Targeted anti-IL-13 therapies in asthma: current data and future perspectives

S. Loukides, P. Bakakos, G. Hillas, 2018, Expert opinion on investigational drugs.

Identification of asthma phenotypes using blood cell count

S. Loukides, A. Papaioannou, P. Bakakos, 2022, EBioMedicine.

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

K. Kostikas, N. Koulouris, S. Loukides, 2017, The journal of allergy and clinical immunology. In practice.

Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences

S. Loukides, N. Rovina, P. Bakakos, 2022, Expert opinion on biological therapy.

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers

K. Kostikas, M. Minas, K. Gourgoulianis, 2011, Respiratory research.

Biological Therapy of Severe Asthma and Nasal Polyps

F. Schleich, P. Bakakos, A. Bakakos, 2022, Journal of personalized medicine.

Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers

K. Kostikas, S. Loukides, S. Papiris, 2011, Respirology.

Sestrin 2 levels are associated with emphysematous phenotype of COPD

N. Koulouris, S. Loukides, A. Papaioannou, 2022, PloS one.

Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study

K. Kostikas, S. Loukides, S. Papiris, 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?

N. Koulouris, S. Loukides, Kazuhiro Ito, 2020, Journal of clinical medicine.

Community-acquired pneumonia: current data

N. Katsikogiannis, P. Zarogoulidis, G. Trakada, 2017 .

The role of non‐invasive modalities for assessing inflammation in patients with non‐cystic fibrosis bronchiectasis

S. Loukides, S. Tsikrika, S. Papiris, 2017, Cytokine.

Asthma‐chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics

K. Kostikas, N. Koulouris, S. Loukides, 2019, Allergy.

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

B. Celli, K. Kostikas, D. Stolz, 2013, Current drug targets.

Carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 (CYFRA 21‐1) levels in induced sputum of lung cancer patients

P. Bakakos, K. Dimakou, G. Hillas, 2008, Scandinavian journal of clinical and laboratory investigation.

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

K. Kostikas, K. Gourgoulianis, K. Samitas, 2022, The Journal of Allergy and Clinical Immunology: In Practice.

The Inflammatory Effector Cell Pattern in Asthma and Chronic Obstructive Pulmonary Disease – What Is It Good for?

C. Kroegel, P. Bakakos, 2011, Respiration.

Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.

N. Koulouris, S. Loukides, A. Tzouvelekis, 2021, Advances in respiratory medicine.

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms

K. Kostikas, N. Koulouris, S. Loukides, 2018, Journal of breath research.

Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

S. Ktena, E. Nicastri, L. Dagna, 2021, medRxiv.

RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

K. Kostikas, K. Samitas, S. Loukides, 2022, Allergy.

Early Treatment of COVID-19 Pneumonia with Anakinra Guided by Urokinase Plasminogen Receptor

M. Netea, S. Ktena, G. Ippolito, 2021 .

Oxidative stress in patients with COPD.

K. Kostikas, S. Loukides, P. Bakakos, 2011, Current drug targets.

Associations between BODE Index and Systemic Inflammatory Biomarkers in COPD

K. Kostikas, K. Gourgoulianis, S. Loukides, 2011, COPD.

Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures

A. Analitis, P. Bakakos, K. Charalabopoulos, 2017, Postgraduate Medical Journal.

Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

K. Kostikas, N. Koulouris, S. Loukides, 2019, The journal of allergy and clinical immunology. In practice.

Serum and Pleural Soluble Cell Adhesion Molecules in Mesothelioma Patients: A Retrospective Cohort Study

E. Kotteas, A. Charpidou, P. Bakakos, 2022, Cancers.

New paradigm in asthma management: Switching between biologics!

S. Loukides, P. Bakakos, M. Mukherjee, 2020, Allergy.

Capturing patient-centered outcomes using innovative technologies in adults with severe eosinophilic asthma on benralizumab: Τhe EMPOWAIR real-world study design

K. Kostikas, S. Loukides, E. Zervas, 2022, Pneumon.

Intracellular cytokine staining for analysis by flow cytometry.

A. Frew, P. Bakakos, J. Madden, 2000, Methods in molecular medicine.

Fever and multilobular mass of the right lung in a young adult with asthma

N. Koulouris, P. Bakakos, A. Sotiriou, 2015, Medical mycology case reports.

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm

K. Kostikas, S. Loukides, P. Bakakos, 2020, ERJ Open Research.

C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia

N. Koulouris, N. Rovina, P. Bakakos, 2022, Journal of Personalized Medicine.

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study

S. Loukides, Demosthenes Bouros, K. Akinosoglou, 2020, Frontiers in Medicine.

IL-26 in the Lung and Its Role in COPD Inflammation

S. Loukides, P. Steiropoulos, A. Papaioannou, 2022, Journal of personalized medicine.

Sleep Apnea and Cardiovascular Risk in Patients with Prediabetes and Type 2 Diabetes

T. Psaltopoulou, C. Vlachopoulos, G. Trakada, 2022, Nutrients.

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, E. Nicastri, 2021, Nature medicine.

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?

E. Nena, P. Steiropoulos, A. Papaioannou, 2022, Journal of personalized medicine.

Protocol, rationale and design of the PHOLLOW cross-sectional and retrospective chart review study to assess the prevalence and characterize the patient profile, clinical features and disease burden of type-2 low severe asthma in routine care settings in Greece

K. Kostikas, K. Samitas, S. Loukides, 2022, Pneumon.

Plasma and Urine Elastase Alpha-1-Proteinase Inhibitor Levels in Neonatal Urinary Tract Infection

D. Anagnostakis, P. Bakakos, H. Mandyla, 2002, Neonatology.

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, G. Ippolito, 2021, Nature Medicine.

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009, European Respiratory Journal.

CRP and PCT as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009 .

Chylothorax and Pseudochylothorax

P. Bakakos, A. Rasidakis, M. Toumbis, 2004 .

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

Biomarkers Guided Treatment Strategies in Adult Patients with Asthma: Ready for the Clinical Field?

S. Loukides, A. Papaioannou, P. Bakakos, 2017, Archivum Immunologiae et Therapiae Experimentalis.

Severe Eosinophilic Asthma

S. Loukides, P. Bakakos, A. Bakakos, 2019, Journal of clinical medicine.

VEGF and IL-18 in induced sputum of lung cancer patients.

C. Roussos, S. Loukides, N. Rovina, 2011, Cytokine.

Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?

K. Kostikas, S. Loukides, P. Bakakos, 2009, Current medicinal chemistry.

Unraveling the Relationship of Asthma and COVID-19

N. Rovina, P. Bakakos, A. Bakakos, 2021, Journal of personalized medicine.

Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Ana C. Coelho, Todor A Popov, I. Pavord, 2020, Clinical and Translational Allergy.

Angiotensin-Converting Enzyme 2 (ACE2) As a Novel Biorecognition Element in A Cell-Based Biosensor for the Ultra-Rapid, Ultra-Sensitive Detection of the SARS-CoV-2 S1 Spike Protein Antigen

G. Chrousos, K. Hatziagapiou, N. Rovina, 2021, Chemosensors.

Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations

K. Kostikas, S. Loukides, D. Perrea, 2014, COPD.

Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease.

K. Kostikas, K. Gourgoulianis, C. Roussos, 2011, European journal of internal medicine.

Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.

S. Loukides, Z. Diamant, A. Papaioannou, 2018, Respiratory medicine.

Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.

P. Bakakos, Anastasios F. Palamidas, P. Galanakis, 2023, Respiratory medicine.

The Economic Burden of Asthma in Greece: A Cross-Sectional Study

S. Loukides, N. Maniadakis, G. Kourlaba, 2019, Applied Health Economics and Health Policy.

The self-reported prevalence and disease burden of asthma in Greece

S. Loukides, N. Maniadakis, G. Kourlaba, 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

Heart rate recovery post 6-minute walking test in obstructive sleep apnea

N. Koulouris, I. Vogiatzis, K. Vougas, 2014, Clinical Research in Cardiology.

Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People

N. Koulouris, G. Tatsis, P. Bakakos, 2018, The open respiratory medicine journal.

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity

N. Papadopoulos, K. Kostikas, S. Loukides, 2022, Journal of personalized medicine.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

K. Kostikas, N. Koulouris, S. Loukides, 2015, Respiratory medicine.

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community

G. Stratakos, N. Koulouris, S. Loukides, 2022, Journal of personalized medicine.

Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.

K. Malagari, P. Bakakos, C. Triantafillidou, 2016, Respiratory medicine.

An algorithmic approach for the treatment of severe uncontrolled asthma

K. Samitas, S. Loukides, E. Zervas, 2018, ERJ Open Research.

Blood eosinophils in COPD: friend or foe?

S. Loukides, A. Papaioannou, P. Bakakos, 2021, Expert review of respiratory medicine.

Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease

P. Bakakos, A. Rasidakis, S. Avgeropoulou, 2009, BMC pulmonary medicine.

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy

P. Bakakos, A. Bakakos, Nikoleta Rovina, 2021, International journal of molecular sciences.

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

P. Bakakos, G. Hillas, F. Vlastos, 2010, Cancer management and research.

Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease

S. Loukides, N. Iacovidou, A. Chalkias, 2017, Heart Failure Reviews.

A late mediastinal complication of EBUS-TBNA: Case report and review of the literature

G. Stratakos, N. Anagnostopoulos, E. Koukaki, 2022, Pneumon.

The effect of stress management incorporating progressive muscle relaxation and biofeedback-assisted relaxation breathing on patients with asthma: a randomised controlled trial

G. Chrousos, C. Darviri, A. Artemiadis, 2019, Advances in Integrative Medicine.

Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients

N. Rovina, A. Koutsoukou, E. Giamarellos‐Bourboulis, 2023, Journal of personalized medicine.

Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece.

T. Katostaras, P. Bakakos, E. Apostolopoulou, 2003, Respiratory care.

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts

V. Aidinis, A. Bennett, Demosthenes Bouros, 2023, Diagnostics.

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial

E. Nicastri, L. Dagna, H. Milionis, 2022, eClinicalMedicine.

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

K. Syrigos, E. Nicastri, L. Dagna, 2022, Cytokine.

Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment

I. Liappas, K. Vougas, E. Manali, 2013, Sleep and Breathing.

Vascular Biomarkers in Asthma and COPD.

A. Papi, P. Bakakos, George Patentalakis, 2016, Current Topics in Medicinal Chemistry.

Clinical Application of the Novel Cell-Based Biosensor for the Ultra-Rapid Detection of the SARS-CoV-2 S1 Spike Protein Antigen: A Practical Approach

D. Iliopoulos, G. Chrousos, G. Lambrou, 2021, Biosensors.

Sputum interleukin‐13 as a biomarker for the evaluation of asthma control

K. Kostikas, S. Papiris, S. Loukides, 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control

K. Kostikas, N. Koulouris, S. Loukides, 2014, Clinical and Translational Allergy.

Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.

C. Roussos, M. Kardara, N. Koulouris, 2016, Respiratory medicine.

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy

M. Idzko, D. Gompelmann, S. Loukides, 2023, Life.

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach

S. Loukides, K. Souliotis, T. Vassilakopoulos, 2017, Front. Public Health.

Severe Asthma in the Era of Biologics: Continuous Challenges

S. Loukides, P. Bakakos, P. Schoini, 2023, Journal of Clinical Medicine.

Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study.

K. Samitas, S. Loukides, E. Zervas, 2021, Allergy and Asthma Proceedings.

Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis

K. Samitas, S. Loukides, E. Zervas, 2020, International Archives of Allergy and Immunology.

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

S. Loukides, N. Hanania, I. Stříž, 2023, Clinical science.

Severe asthma: anti-IgE or anti-IL-5?

S. Loukides, P. Bakakos, E. Papathanassiou, 2015, European clinical respiratory journal.

Asthma: From Phenotypes to Personalized Medicine

P. Bakakos, 2022, Journal of personalized medicine.

An update on asthma diagnosis.

N. Siafakas, P. Katsaounou, P. Bakakos, 2023, Journal of Asthma.

Ten years of the website for patients with asthma (www.myasthma.gr) by the Asthma Working Group of the Hellenic Thoracic Society

K. Samitas, P. Bakakos, E. Fouka, 2023, Pneumon.

Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission

S. Loukides, N. Rovina, A. Papaioannou, 2023, Expert review of respiratory medicine.

"Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study - The TRIBUNE study".

K. Bartziokas, P. Katerelos, P. Bakakos, 2023, Respiratory medicine.

Biologics in severe asthma: the overlap endotype - opportunities and challenges

O. Usmani, S. Loukides, P. Bakakos, 2020, Expert opinion on biological therapy.

Smoking asthma phenotype: diagnostic and management challenges

K. Kostikas, S. Loukides, P. Bakakos, 2016, Current opinion in pulmonary medicine.

Prospective evaluation for inhalation devices in greek patients with COPD and asthma: The PAIR study.

G. Stratakos, E. Zervas, D. Bouros, 2019, Pulmonary pharmacology & therapeutics.

Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.

G. Stratakos, D. Orphanidou, P. Bakakos, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Investigation of the Health Effects of Workers Exposed to Respirable Crystalline Silica during Outdoor and Underground Construction Projects in Greece

Ioannis C. Konstantakopoulos, A. Lazaris, E. Patsouris, 2020 .

Air Pollution and Hospital Admission for Respiratory Diseases in Athens, Greece

E. Zervas, G. Dounias, P. Katsaounou, 2019, Occupational and environmental health.

EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.

I. Pavord, V. Backer, D. Ryan, 2023, Respiratory Medicine.

Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference?

K. Kostikas, N. Koulouris, S. Loukides, 2018, Journal of Thoracic Disease.

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study

K. Kostikas, N. Koulouris, S. Loukides, 2017, COPD.

Epidemiological characteristics, clinical features and outcomes of patients with COVID-19 admitted to seven reference centers across Greece: An observational study during the fourth and fifth waves of the COVID-19 pandemic

K. Kostikas, S. Loukides, Emmanouil Alevrakis, 2023, Pneumon.